Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic cord blood regulatory T cells can resolve lung inflammation.
Lyu MA, Huang M, Zeng K, Li L, Khoury JD, Nishimoto M, Ma H, Sadeghi T, Mukherjee S, Slutsky AS, Flowers CR, Parmar S. Lyu MA, et al. Among authors: zeng k. Cytotherapy. 2023 Mar;25(3):245-253. doi: 10.1016/j.jcyt.2022.10.009. Epub 2022 Nov 24. Cytotherapy. 2023. PMID: 36437190
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS.
Gladstone DE, D'Alessio F, Howard C, Lyu MA, Mock JR, Gibbs KW, Abrams D, Huang M, Zeng K, Herlihy JP, Castillo ST, Bassett R, Sadeghi T, Parmar S, Flowers CR, Mukherjee S, Schoenfeld D, Thall PF, Slutsky AS. Gladstone DE, et al. Among authors: zeng k. Blood Adv. 2023 Jul 11;7(13):3075-3079. doi: 10.1182/bloodadvances.2022009619. Blood Adv. 2023. PMID: 36961352 Free PMC article. Clinical Trial. No abstract available.
Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes.
Kadia TM, Huang M, Pemmaraju N, Abbas HA, Ly C, Masarova L, Yilmaz M, Lyu MA, Zeng K, Sadeghi T, Cook R, DiNardo CD, Daver N, Issa GC, Jabbour E, Borthakur G, Jain N, Garcia-Manero G, Parmar S, Flowers C, Kantarjian H, Verstovsek S. Kadia TM, et al. Among authors: zeng k. NEJM Evid. 2024 Jun;3(6):EVIDoa2300362. doi: 10.1056/EVIDoa2300362. Epub 2024 May 28. NEJM Evid. 2024. PMID: 38804782 Clinical Trial.
Influence of TP53 mutation on efficacy and survival in advanced EGFR-mutant non-small cell lung cancer patients treated with third-generation EGFR tyrosine kinase inhibitors.
Zhang Z, Xue J, Yang Y, Fang W, Huang Y, Zhao S, Luo F, Cao J, Zeng K, Ma W, Zhan J, Lu F, Zhang L, Zhao H. Zhang Z, et al. Among authors: zeng k. MedComm (2020). 2024 Jun 2;5(6):e586. doi: 10.1002/mco2.586. eCollection 2024 Jun. MedComm (2020). 2024. PMID: 38832214 Free PMC article.
Development and validation of a nomogram based on perioperative risk factors for the prediction of early thrombotic complications following pediatric liver transplantation.
You Q, Qu E, Zeng K, Liu J, Yang Q, Tang H, Feng X, Yao J, Huang X, Zhang T, Fu B, Li H, Zhao H, Zheng J, Yi S, Yang Y. You Q, et al. Among authors: zeng k. Chin Med J (Engl). 2024 May 30. doi: 10.1097/CM9.0000000000003137. Online ahead of print. Chin Med J (Engl). 2024. PMID: 38816681 No abstract available.
1,395 results